scispace - formally typeset
C

Costantino Iadecola

Researcher at Cornell University

Publications -  468
Citations -  59815

Costantino Iadecola is an academic researcher from Cornell University. The author has contributed to research in topics: Stroke & Ischemia. The author has an hindex of 107, co-authored 435 publications receiving 51044 citations. Previous affiliations of Costantino Iadecola include University of Chicago & University of Minnesota.

Papers
More filters
Journal ArticleDOI

Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.

TL;DR: Accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles and vascular disease, including stroke, have better cognitive function and lower dementia rates and the World Stroke Organization has issued a proclamation calling for the joint prevention of stroke and dementia.
Journal ArticleDOI

Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation.

TL;DR: This paper found that microglial CD36 is a key determinant of post-ischemic IL-1β production by regulating caspase-1 activity, whereas endothelial CD36 was required for the full expression of the endothelial activation induced by IL 1β.
Posted ContentDOI

Endogenous protection from ischemic brain injury by preconditioned monocytes

TL;DR: This model of neuroprotection may facilitate clinical efforts to increase the efficacy of bone marrow mononuclear cell treatments in acute neurological diseases such as cerebral ischemia and provide the rationale for cell therapies based on the delivery of autologous or allogeneic protective monocytes into patients with ischemic stroke.
Journal ArticleDOI

Vascular Cognitive Impairment: Small Vessels, Big Toll Introduction

TL;DR: The emphasis was on cerebrovascular dysregulation and small vessel white matter disease, drawing from animal models, human pathology, neuroimaging, epidemiology, and the recent clinical trial in CADASIL, as summarized below.
Journal ArticleDOI

Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events

TL;DR: A heightened risk of arterial isChemic events driven by an increased risk of ischemic stroke, in the 4 weeks after nontraumatic SDH is found, due to interruption of antithrombotic therapy after SDH diagnosis.